In prostate cancer, ET-1 also promotes cancer cell proliferation and enhances the mitogenic effects of other growth factors including IGF-1, platelet-derived growth factor (PDGF), and epidermal growth factor (EGF) [37]. Here, EGF is linked to prostate cancer.